| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 07/04/2002 | DE10065710A1 Arzneimittel enthaltend ein Polyamin als Wirksubstanz A medicament comprising a polyamine as the active substance |
| 07/04/2002 | DE10064994A1 Sulfamidothienopyrimidine Sulfamidothienopyrimidine |
| 07/04/2002 | DE10063435A1 Chinazolinderviate,diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung Chinazolinderviate, medicaments containing these compounds, their use and process for their preparation |
| 07/04/2002 | DE10059144A1 Modulation der Transkription pro-inflammatorischer Genprodukte Modulating the transcription of pro-inflammatory gene products |
| 07/04/2002 | CA2782510A1 Polypeptides |
| 07/04/2002 | CA2436777A1 A screening assay for antagonists of human leukocyte receptors |
| 07/04/2002 | CA2436739A1 Combination agent |
| 07/04/2002 | CA2433520A1 Novel compounds and compositions as cathepsin inhibitors |
| 07/04/2002 | CA2433090A1 Dipeptidyl peptidase iv inhibitor |
| 07/04/2002 | CA2432542A1 Methods of modulating toll-related receptor (trr) signaling |
| 07/04/2002 | CA2431835A1 Induction of tolerance |
| 07/04/2002 | CA2430930A1 Helicobacter proteins, nucleic acids and uses thereof |
| 07/04/2002 | CA2430691A1 Immunomodulatory polynucleotides and methods of using the same |
| 07/03/2002 | EP1219638A2 G-protein coupled receptors having homology to the P2Y purinoreceptor 1 (P2Y1) |
| 07/03/2002 | EP1219630A1 Immunopotentiating compositions |
| 07/03/2002 | EP1219612A1 2-imino-1,3-thiazine derivatives |
| 07/03/2002 | EP1219606A1 Tricyclic compounds bearing acyloxymethoxycarbonyl pendants |
| 07/03/2002 | EP1219599A1 Vitamin d derivatives having substituents at the 2 alpha-position |
| 07/03/2002 | EP1219596A1 Salicylamide derivatives |
| 07/03/2002 | EP1219301A1 Vaccines containing hybrid polypeptides consisting of at least two different allergenic proteins |
| 07/03/2002 | EP1219300A1 Allergy vaccines |
| 07/03/2002 | EP1218751A2 Diagnosis of coeliac disease using a gliadin epitope |
| 07/03/2002 | EP1218544A1 Methods for identifying rna binding compounds |
| 07/03/2002 | EP1218527A2 Adenoviral vectors for treating disease |
| 07/03/2002 | EP1218521A1 Use of soluble costimulatory factor for tumor immuno-gene therapy |
| 07/03/2002 | EP1218518A1 Dna polymerase lambda and uses thereof |
| 07/03/2002 | EP1218514A1 Designing immunogens |
| 07/03/2002 | EP1218509A2 Fibroblast growth factor-like polypeptides |
| 07/03/2002 | EP1218507A1 Monoclonal antibody 3f1h10 neutralising vhsv (viral haemorrhagic septicaemia virus) |
| 07/03/2002 | EP1218504A2 Gl50 molecules and uses therefor |
| 07/03/2002 | EP1218491A1 Dna encoding a human subunit 5-ht3-c of the 5-ht3 serotonin receptor |
| 07/03/2002 | EP1218412A2 Human g-protein coupled receptor |
| 07/03/2002 | EP1218408A1 32 human secreted proteins |
| 07/03/2002 | EP1218397A1 Attractin-like polynucleotides, polypeptides, and antibodies |
| 07/03/2002 | EP1218376A1 Tyrosine kinase inhibitors |
| 07/03/2002 | EP1218375A1 Pharmaceutically active sulfonyl amino acid derivatives |
| 07/03/2002 | EP1218374A1 Pharmaceutically active sulfonamide derivatives |
| 07/03/2002 | EP1218373A2 2-pyrazolin-5-ones as tyrosine kinase inhibitors |
| 07/03/2002 | EP1218372A1 Novel spiroheterocyclic compounds useful as reversible inhibitors of cysteine proteases |
| 07/03/2002 | EP1218369A1 INHIBITORS OF c-JUN N-TERMINAL KINASES (JNK) AND OTHER PROTEIN KINASES |
| 07/03/2002 | EP1218358A1 Therapeutic quinazoline compounds |
| 07/03/2002 | EP1218353A1 Quinazoline derivatives |
| 07/03/2002 | EP1218347A1 Pyrazoloanthrone and derivatives thereof as jnk inhibitors and their compositions |
| 07/03/2002 | EP1218333A1 Anti-inflammatory nitro- and thia- fatty acids |
| 07/03/2002 | EP1218064A2 Compositions for treating autoimmune disease containing a compounds which regulates icam-lfa-1 interaction and a compounds which regulates cd40-cd40 ligand interaction |
| 07/03/2002 | EP1218049A2 Methods and apparatus for relieving headaches, rhinitis and other common ailments |
| 07/03/2002 | EP1218031A2 Pharmaceutical composition comprising an antigen |
| 07/03/2002 | EP1218030A1 Methods and compositions for the treatment and prevention of graft rejection using heat shock proteins |
| 07/03/2002 | EP1218028A1 Dendritic cells activated in the presence of glucocorticoid hormones are capable of suppressing antigenspecific t cell responses |
| 07/03/2002 | EP1218014A2 Compositions comprising progesterone or progesterone analogs for the treatment of inflammatory conditions |
| 07/03/2002 | EP1218013A2 Phospholipid prodrugs of anti-proliferative drugs |
| 07/03/2002 | EP1218007A1 Optically active isomers of ketotifen and therapeutically active metabolites thereof |
| 07/03/2002 | EP1218000A1 Anti-cancer nitro- and thia-fatty acids |
| 07/03/2002 | EP1217996A1 Use of xanthophylls, astaxanthin e.g., for treatment of autoimmune diseases, chronic viral and intracellular bacterial infections |
| 07/03/2002 | EP1217975A1 Using quaternary ammonium salts for transdermal drug delivery |
| 07/03/2002 | EP1217902A1 Nutritional compositions which contain non-digestible polysaccharides and use thereof to reduce transport through tight junctions |
| 07/03/2002 | EP0983235B1 Leukotriene b4 derivatives, in particular oximo-ltb4 antagonists |
| 07/03/2002 | EP0983234B1 Leukotriene b 4 derivatives, in particular 7-methylcyclohexyl-ltb 4 antagonists |
| 07/03/2002 | EP0912085A4 Precise efficacy assay methods for active agents including chemotherapeutic agents |
| 07/03/2002 | CN1357050A Adenoviral vectors for treating disease |
| 07/03/2002 | CN1357009A Humanized antibody specific for human 4-1BB and pharmaceutical compsn comprising same |
| 07/03/2002 | CN1357002A Compositions for treating inflammatory response |
| 07/03/2002 | CN1356986A Spiroimidazolidine derivatives, their prepn. their use and pharmaceutical prepns. comprising them |
| 07/03/2002 | CN1356911A Method for treatment of fibrosis using antagonist of integrin alpha-4 subunit |
| 07/03/2002 | CN1356910A Model membrane systems |
| 07/03/2002 | CN1356907A Fish serine proteinases and their pharmaceutical and cosmetic use |
| 07/03/2002 | CN1356905A Leaves of cajanus cajan(L.) millsp and extract, formulation and uses thereof |
| 07/03/2002 | CN1356061A Multi-purpose high-function solution composition, its preparing process and its usage as non-specific immanopotentiator |
| 07/02/2002 | US6414153 1-phenylpydrrolidin-2-ones and -thiones and 1-(4-pyridyl)pydrrolidin-2-ones and -thiones which are useful in the treatment of inflammatory disease |
| 07/02/2002 | US6414148 Produce antiangiogenic and/or vascular permeability reducing effect in warm-blooded animals |
| 07/02/2002 | US6414117 Compositions and methods for the treatment and diagnosis of immune disorders |
| 07/02/2002 | US6414025 Rheumatic disorders; antiinflammatory agents; autoimmune diseases |
| 07/02/2002 | US6414014 Calibration dosage; side effect reduction |
| 07/02/2002 | US6413996 Diaminocyclobutene-3,4-dione derivatives, their preparation and use |
| 07/02/2002 | US6413995 Immunomodulators |
| 07/02/2002 | US6413990 Antiinflammatory agents, antiallergens |
| 07/02/2002 | US6413975 Purine derivatives having phosphodiesterase iv inhibition activity |
| 07/02/2002 | US6413963 Alpha, beta-integrin inhibitors used in the treatment of multiple sclerosis, atherosclerosis, asthma and inflammatory bowel disease |
| 07/02/2002 | US6413952 Agonizing dimeric cell-surface receptors with a receptor binding moiety and chelating metal |
| 07/02/2002 | US6413936 Glycomimetics as selectin antagonists and pharmaceuticals having antiinflammatory activity |
| 07/02/2002 | US6413762 Viral nucleotide sequences |
| 07/02/2002 | US6413738 House dust mite allergen, Der f VII, and uses therefor |
| 07/02/2002 | US6413731 Methods of screening for compounds which bind to a human SNORF36A receptor |
| 07/02/2002 | US6413553 Herbal formulation of a combination of Piper betel and Murrya koenigii extracts for blocking 5 lipoxygenase activity |
| 07/02/2002 | US6413547 Thermotropic; antibiotics; antiinflammatory agents; antihistamines |
| 07/02/2002 | US6413520 Methods of immunizing adults using anti-meningococcal vaccine compositions |
| 07/02/2002 | US6413516 Suppression lymphocytes |
| 07/02/2002 | US6413514 Methods of using antibodies against human CD40 |
| 07/02/2002 | CA2333528C A stabilized antihistamine syrup containing aminopolycarboxylic acid as stabilizer |
| 07/02/2002 | CA2047283C Pyrazolopyridine compound and processes for preparation thereof |
| 06/27/2002 | WO2002050289A1 Methods for the production of multimeric proteins, and related compositions |
| 06/27/2002 | WO2002050284A2 Oxidoreductases |
| 06/27/2002 | WO2002050279A2 Nucleic acid-associated proteins |
| 06/27/2002 | WO2002050270A1 Novel tissue-specific secretory polypeptide and dna thereof |
| 06/27/2002 | WO2002050269A1 Method of examining allergic disease |
| 06/27/2002 | WO2002050255A2 Isolated human dehydrogenases, nucleic acid molecules encoding them, and uses thereof |
| 06/27/2002 | WO2002050250A2 Signal-1/signal-2 bifunctional peptide inhibitors |
| 06/27/2002 | WO2002050120A2 High affinity antibodies |
| 06/27/2002 | WO2002050119A2 Method for modulating the binding activity of a novel icam-3 binding receptor on sinusoidal endothelial cells in liver and lymph nodes |
| 06/27/2002 | WO2002050108A2 Immunogenic glycopeptides, screening, preparation and uses |